The report provides value (USD million), volume (units) and average price (USD) data for each sector and sub-segment within seven industry categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants with data on company key figures and new product development, wherever available.


Scope of the Research

- Industry size and market share data for In Vitro Diagnostics (IVD) industry categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
- Annualized industry revenues (USD million), volume (units) and average price (USD) data for each of the sectors and sub-segments within seven industry categories. Data from 2002 to 2009, projection forward for 7 years to 2016.
- 2009 industry player shares and distribution shares data for each of the seven industry categories.
- Global corporate-level profiles of key industry players operating within the China In Vitro Diagnostics (IVD) industry .
- Key Companies covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Why Should You Get This Report?

- Develop innovative strategies by selecting the key market segment expected to grow .
- Develop successful market-entry strategies .
- Understand and respond to your competition by identifying who-stands-where in the China In Vitro Diagnostics (IVD) competitive landscape.
- Facilitate better investment decision making by identifying the key industry sectors expected to register strong growth in the near future.
- What are the best distribution channels and what’s the most preferred mode of product distribution – Identify, understand and decide.

Table Of Contents

1 Table of Contents 2
I. 1 List of Data tables 10
I. 2 List of Charts 13

II Introduction 16
II. 1 About this Report and the Author 16

III In Vitro Diagnostics In China 17
III. 1 In Vitro Diagnostics, March ket Segmentation 17
III. 2 In Vitro Diagnostics, China, Overall Sales (USD Million), from 2002 to 2016 18
III. 3 In Vitro Diagnostics March ket, China, Sales Mix (USD Million), 2009 20
III. 4 In Vitro Diagnostics March ket, China, Segment Contribution (%), 2009 21
III. 5 In Vitro Diagnostics, China, Market Shares (2008-2009) 27

IV Clinical Chemistry In China 28
IV. 1 Clinical Chemistry, March ket Segmentation 28
IV. 2 Clinical Chemistry March ket, China, Sales Mix (USD Million), 2009 29
IV. 3 Clinical Chemistry March ket, China, Segment Contribution (%), 2009 30
IV. 4 Clinical Chemistry Overall Sales (from 2002 to 2016 ) 31
IV. 4.1 Clinical Chemisty Analyzers Sales (from 2002 to 2016 ) 35
IV. 4.2 Urine Analysis Sales (from 2002 to 2016 ) 39
IV. 5 Clinical Chemistry Distribution Channel (2008-2009) 43
IV. 6 Clinical Chemistry, China, Market Shares (2008-2009) 44

V Genetic Testing In China 46
V. 1 Genetic Testing, March ket Segmentation 46
V. 2 Genetic Testing March ket, China, Sales Mix (USD Million), 2009 47
V. 3 Genetic Testing March ket, China, Segment Contribution (%), 2009 48
V. 4 Genetic Testing Overall Sales (from 2002 to 2016 ) 49
V. 5 Genetic Testing Distribution Channel (2008-2009) 53
V. 6 Genetic Testing, China, Market Shares (2008-2009) 54

VI Haematology In China 55
VI. 1 Haematology, March ket Segmentation 55
VI. 2 Haematology March ket, China, Sales Mix (USD Million), 2009 56
VI. 3 Haematology March ket, China, Segment Contribution (%), 2009 57
VI. 4 Haematology Overall Sales (from 2002 to 2016 ) 58
VI. 4.1 Haematology Reagents Sales (from 2002 to 2016 ) 62
VI. 4.2 Immunohaematology Sales (from 2002 to 2016 ) 66
VI. 4.3 Haemostasis Sales (from 2002 to 2016 ) 70
VI. 4.4 Haematology Rapid Tests Sales (from 2002 to 2016 ) 74
VI. 4.5 Haematology Cell Counters Sales (from 2002 to 2016 ) 78
VI. 5 Haematology Distribution Channel (2008-2009) 82
VI. 6 Haematology, China, Market Shares (2008-2009) 83

VII Histology And Cytology In China 85
VII. 1 Histology and Cytology, March ket Segmentation 85
VII. 2 Histology and Cytology March ket, China, Sales Mix (USD Million), 2009 86
VII. 3 Histology And Cytology March ket, China, Segment Contribution (%), 2009 87
VII. 4 Histology And Cytology Overall Sales (from 2002 to 2016 ) 88
VII. 4.1 Histology Sales (from 2002 to 2016 ) 92
VII. 5 Histology And Cytology Distribution Channel (2008-2009) 96
VII. 6 Histology And Cytology, China, Market Shares (2008-2009) 97

VIII Immuno Chemistry In China 98
VIII. 1 Immuno Chemistry, March ket Segmentation 98
VIII. 2 Immuno Chemistry March ket, China, Sales Mix (USD Million), 2009 99
VIII. 3 Immuno Chemistry March ket, China, Segment Contribution (%), 2009 100
VIII. 4 Immuno Chemistry Overall Sales (from 2002 to 2016 ) 101
VIII. 4.1 Disease Specific Immunochemistry Sales (from 2002 to 2016 ) 105
VIII. 4.2 Drug Related Testing Sales (from 2002 to 2016 ) 109
VIII. 4.3 Endocrinology Tests Sales (from 2002 to 2016 ) 112
VIII. 4.4 Immunochemistry Analyzers Sales (from 2002 to 2016 ) 116
VIII. 5 Immuno Chemistry Distribution Channel (2008-2009) 120
VIII. 6 Immuno Chemistry, China, Market Shares (2008-2009) 121

IX Infectious Immunology In China 123
IX. 1 Infectious Immunology, March ket Segmentation 123
IX. 2 Infectious Immunology March ket, China, Sales Mix (USD Million), 2009 124
IX. 3 Infectious Immunology March ket, China, Segment Contribution (%), 2009 125
IX. 4 Infectious Immunology Overall Sales (from 2002 to 2016 ) 126
IX. 5 Infectious Immunology Distribution Channel (2008-2009) 130
IX. 6 Infectious Immunology, China, Market Shares (2008-2009) 131

X Microbiology Culture In China 133
X. 1 Microbiology Culture, March ket Segmentation 133
X. 2 Microbiology Culture March ket, China, Sales Mix (USD Million), 2009 134
X. 3 Microbiology Culture March ket, China, Segment Contribution (%), 2009 135
X. 4 Microbiology Culture Overall Sales (from 2002 to 2016 ) 136
X. 4.1 Microbiology Analyzers Sales (from 2002 to 2016 ) 140
X. 5 Microbiology Culture Distribution Channel (2008-2009) 143
X. 6 Microbiology Culture, China, Market Shares (2008-2009) 144

XI Overview of Key Firms in China In Vitro Diagnostics March ket 145
XI. 1 F. Hoffmann-La Roche Ltd. 145
XI. 1.1 Company Profile 145
XI. 1.2 Share in the China In Vitro Diagnostics March ket 145
XI. 2 Siemens Healthcare 146
XI. 2.1 Company Profile 146
XI. 2.2 Share in the China In Vitro Diagnostics March ket 146
XI. 3 Abbott LaboratoriesCompany Overview 147
XI. 3.1 Share in the China In Vitro Diagnostics March ket 147
XI. 4 Beckman Coulter, Inc. 148
XI. 4.1 Company Profile 148
XI. 4.2 Share in the China In Vitro Diagnostics March ket 148
XI. 5 Sysmex Corporation 149
XI. 5.1 Company Profile 149
XI. 5.2 Share in the China In Vitro Diagnostics March ket 149
XI. 6 Mindray Medical International Limited 150
XI. 6.1 Company Profile 150
XI. 6.2 Share in the China In Vitro Diagnostics March ket 150
XI. 7 OLYMPUS CORPORATION 151
XI. 7.1 Company Profile 151
XI. 8 Inverness Medical Innovations, Inc. 151
XI. 8.1 Company Profile 151
XI. 9 Becton, Dickinson and Firms 152
XI. 9.1 Company Profile 152
XI. 10 bioMerieux S.A. 152
XI. 10.1 Company Profile 152
XI. 11 Bio-Rad Laboratories, Inc. 153
XI. 11.1 Company Profile 153
XI. 12 Hologic, Inc. 153
XI. 12.1 Company Profile 153
XI. 13 Ventana Medical Systems, Inc. 154
XI. 13.1 Company Profile 154
XI. 14 Ortho-Clinical Diagnostics Inc. 154
XI. 14.1 Company Profile 154
XI. 15 DiaSorin S.p.A 154
XI. 15.1 Company Profile 154
XI. 16 Qiagen N.V. 155
XI. 16.1 Company Profile 155
XI. 17 Gen-Probe Incorporated 155
XI. 17.1 Company Profile 155
XI. 18 Phadia AB 155
XI. 18.1 Company Profile 155
XI. 19 Chengdu Perlong Medical Equipment Co., Ltd. 156
XI. 19.1 Company Profile 156
XI. 20 Shanghai Kehua Bio-engineering Co., Ltd. 156
XI. 20.1 Company Profile 156
XI. 21 China Medical Technologies, Inc. 156
XI. 21.1 Company Profile 156
XI. 22 Shanghai Genomics, Inc. 157
XI. 22.1 Company Profile 157
XI. 23 Beijing Chemclin Biotech Co., Ltd. 157
XI. 23.1 Company Profile 157
XI. 24 Beijing Pason Pharmaceuticals Inc. 157
XI. 24.1 Company Profile 157
XI. 25 Jingmei Biotech Co.,Ltd. 158
XI. 25.1 Company Profile 158
XI. 26 Beijing Bio-Ekon Biotechnology Co., Ltd. 158
XI. 26.1 Company Profile 158
XI. 27 China Sky One Medical, Inc. 158
XI. 27.1 Company Profile 158
XI. 28 Beijing Sekisui Trank Medical Technology Co., Ltd. 159
XI. 28.1 Company Profile 159
XI. 29 Shanghai Xunda Medical Instrument Co.,Ltd 159
XI. 29.1 Company Profile 159
XI. 30 Shanghai Fosun Medical Technology Development Co., Ltd. 159
XI. 30.1 Company Profile 159
XI. 31 Sichuan Nigale Biomedical Inc. 160
XI. 31.1 Company Profile 160
XI. 32 URIT Medical Electronic Group Co., Ltd 160
XI. 32.1 Company Profile 160
XI. 33 Rayto Life and Analytical Sciences Co., Ltd. 160
XI. 33.1 Company Profile 160
XI. 34 Bioson Corporation 161
XI. 34.1 Company Profile 161
XI. 35 Da An Gene Co., Ltd. 161
XI. 35.1 Company Profile 161
XI. 36 Shenzhen PG Biotech Co., Ltd. 161
XI. 36.1 Company Profile 161
XI. 37 Harbin First Bio-Engineering Co., Ltd 161
XI. 37.1 Company Profile 161
XI. 38 Beijing Shining Sun Technology Co., Ltd. 162
XI. 38.1 Company Profile 162
XI. 39 InTec Products, Inc 162
XI. 39.1 Company Profile 162
XI. 40 Zhongshan Bio-Tech Co., Ltd 162
XI. 40.1 Company Profile 162
XI. 41 Beijing BGI-GBI Biotech Co.,Ltd. 162
XI. 41.1 Company Profile 162
XI. 42 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., 163
XI. 42.1 Company Profile 163
XI. 43 GUANG ZHOU BGH BIOCHEMICAL CO.,LTD 163
XI. 43.1 Company Profile 163

XII In Vitro Diagnostics March ket Pipeline Products 164
XII. 1 Clinical Chemisty March ket Pipeline Products 164
XII. 2 Immuno Chemistry March ket Pipeline Products 166
XII. 3 Haematology March ket Pipeline Products 167
XII. 4 Infectious Immunology March ket Pipeline Products 168
XII. 5 Microbiology Culture March ket Pipeline Products 170
XII. 6 Histology and Cytology March ket Pipeline Products 171
XII. 7 Genetic Testing March ket Pipeline Products 172

XIII Financial Deals Landscape 174
XIII. 1 Acquisition 174
XIII. 1.1 CCS Capital to Acquire Beijing Biochem Hengye Science and Technology Development 174
XIII. 1.2 bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai) 175
XIII. 1.3 PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 176
XIII. 2 Partner agreements 177
XIII. 2.1 QIAGEN Enters Into Distribution Agreement With Celera 177
XIII. 2.2 Sequenom Enters Into Licensing Agreement With Optherion 178
XIII. 2.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 179
XIII. 2.4 Response Biomedical Concludes a New Deal With Guangzhou Wondfo Biotech 180
XIII. 2.5 OraSure Technologies Concludes a New Deal With Roche Diagnostics 181
XIII. 2.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 182
XIII. 2.7 DxS Signs Cross-Licensing Agreement With Epigenomics 183

XIV Recent Developments 184
XIV. 1 Company Vision and Strategy 184
XIV. 1.1 September 08, 2009: Qiagen Inaugurates New Asia Headquarters In Shanghai 184
XIV. 2 Legal and Regulatory 184
XIV. 2.1 March 08, 2010: Chinmax Medical Systems Files Complaint In China Against Inverness Medical Beijing Over Distribution Rights 184
XIV. 3 Product News 185
XIV. 3.1 June 09, 2010: China Medical Technologies Receives SFDA Approval For Its SPR-Based HPV-DNA Chip 185
XIV. 3.2 April 14, 2010: HairDX Forms Alliance With GBIL To Distribute HairDX Genetic Hair Loss Tests In Hong Kong And Singapore 185
XIV. 3.3 December 01, 2009: China Sky One Medical Distributes AMI Diagnostic Kit And Human Urinary Albumin Elisa Kit In Southeast Asia Through MDK 186
XIV. 3.4 November 25, 2009: China Sky One Medical Achieves Milestone For Its Two New Biological Testing Kits 186
XIV. 3.5 October 19, 2009: China Medical Technologies Receives SFDA Clearance For SPR System 187

XV Appendix 188
XV. 1 Definitions of March kets Covered in the Report 189
XV. 1.1 In Vitro Diagnostics 189
XV. 2 Research Methodology 197
XV. 3 Secondary Research 198
XV. 4 Primary Research 198
XV. 5 Models 199
XV. 6 Forecasted data s 199
XV. 7 Expert Panels 199
XV. 8 GlobalData Consulting 199
XV. 9 Currency Conversion 200
XV. 10 Contact Us 200
XV. 11 Disclaimer 200

1.1 List of Data tables
Data table 1: In Vitro Diagnostics, China, Overall Sales (USD Million), from 2002 to 2016 19
Data table 2: In Vitro Diagnostics March ket, China, Segment Contribution (%), 2009 21
Data table 3: In Vitro Diagnostics, China, Cross-Category Analysis, from 2002 to 2016 22
Data table 4: In Vitro Diagnostics, China, Overall Sales (USD Million), Historical data, from 2002 to 2009 24
Data table 5: In Vitro Diagnostics, China, Overall Sales (USD Million), Forecasted data, from 2009 to 2016 26
Data table 6: In Vitro Diagnostics, China, Market Shares by Sales (USD Million), from 2008 to 2009 27
Data table 7: Clinical Chemistry March ket, China, Segment Contribution (%), 2009 30
Data table 8: Clinical Chemistry, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 32
Data table 9: Clinical Chemistry, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 34
Data table 10: Clinical Chemisty Analyzers, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 36
Data table 11: Clinical Chemisty Analyzers, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 38
Data table 12: Urine Analysis, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 40
Data table 13: Urine Analysis, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 42
Data table 14: Clinical Chemistry, China, Distribution Channel by Sales (USD Million), from 2008 to 2009 43
Data table 15: Clinical Chemistry, China, Market Shares by Sales (USD Million), from 2008 to 2009 45
Data table 16: Genetic Testing March ket, China, Segment Contribution (%), 2009 48
Data table 17: Genetic Testing, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 50
Data table 18: Genetic Testing, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 52
Data table 19: Genetic Testing, China, Distribution Channel by Sales (USD Million), from 2008 to 2009 53
Data table 20: Genetic Testing, China, Market Shares by Sales (USD Million), from 2008 to 2009 54
Data table 21: Haematology March ket, China, Segment Contribution (%), 2009 57
Data table 22: Haematology, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 59
Data table 23: Haematology, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 61
Data table 24: Haematology Reagents, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 63
Data table 25: Haematology Reagents, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 65
Data table 26: Immunohaematology, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 67
Data table 27: Immunohaematology, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 69
Data table 28: Haemostasis, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 71
Data table 29: Haemostasis, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 73
Data table 30: Haematology Rapid Tests, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 75
Data table 31: Haematology Rapid Tests, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 77
Data table 32: Haematology Cell Counters, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 79
Data table 33: Haematology Cell Counters, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 81
Data table 34: Haematology, China, Distribution Channel by Sales (USD Million), from 2008 to 2009 82
Data table 35: Haematology, China, Market Shares by Sales (USD Million), from 2008 to 2009 84
Data table 36: Histology And Cytology March ket, China, Segment Contribution (%), 2009 87
Data table 37: Histology And Cytology, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 89
Data table 38: Histology And Cytology, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 91
Data table 39: Histology, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 93
Data table 40: Histology, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 95
Data table 41: Histology And Cytology, China, Distribution Channel by Sales (USD Million), from 2008 to 2009 96
Data table 42: Histology And Cytology, China, Market Shares by Sales (USD Million), from 2008 to 2009 97
Data table 43: Immuno Chemistry March ket, China, Segment Contribution (%), 2009 100
Data table 44: Immuno Chemistry, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 102
Data table 45: Immuno Chemistry, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 104
Data table 46: Disease Specific Immunochemistry, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 106
Data table 47: Disease Specific Immunochemistry, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 108
Data table 48: Drug Related Testing, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 109
Data table 49: Drug Related Testing, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 111
Data table 50: Endocrinology Tests, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 113
Data table 51: Endocrinology Tests, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 115
Data table 52: Immunochemistry Analyzers, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 117
Data table 53: Immunochemistry Analyzers, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 119
Data table 54: Immuno Chemistry, China, Distribution Channel by Sales (USD Million), from 2008 to 2009 120
Data table 55: Immuno Chemistry, China, Market Shares by Sales (USD Million), from 2008 to 2009 122
Data table 56: Infectious Immunology March ket, China, Segment Contribution (%), 2009 125
Data table 57: Infectious Immunology, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 127
Data table 58: Infectious Immunology, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 129
Data table 59: Infectious Immunology, China, Distribution Channel by Sales (USD Million), from 2008 to 2009 130
Data table 60: Infectious Immunology, China, Market Shares by Sales (USD Million), from 2008 to 2009 132
Data table 61: Microbiology Culture March ket, China, Segment Contribution (%), 2009 135
Data table 62: Microbiology Culture, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 137
Data table 63: Microbiology Culture, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 139
Data table 64: Microbiology Analyzers, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 141
Data table 65: Microbiology Analyzers, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 142
Data table 66: Microbiology Culture, China, Distribution Channel by Sales (USD Million), from 2008 to 2009 143
Data table 67: Microbiology Culture, China, Market Shares by Sales (USD Million), from 2008 to 2009 144
Data table 68: Clinical Chemisty March ket Pipeline Products 164
Data table 69: Immuno Chemistry March ket Pipeline Products 166
Data table 70: Haematology March ket Pipeline Products 167
Data table 71: Infectious Immunology March ket Pipeline Products 168
Data table 72: Microbiology Culture March ket Pipeline Products 170
Data table 73: Histology and Cytology March ket Pipeline Products 171
Data table 74: Genetic Testing March ket Pipeline Products 172
Data table 75: CCS Capital To Take Over Beijing Biochem Hengye Science and Technology Development 174
Data table 76: bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai) 175
Data table 77: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 176
Data table 78: QIAGEN Enters Into Distribution Agreement With Celera 177
Data table 79: Sequenom Enters Into Licensing Agreement With Optherion 178
Data table 80: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 179
Data table 81: Response Biomedical Concludes a New Deal With Guangzhou Wondfo Biotech 180
Data table 82: OraSure Technologies Concludes a New Deal With Roche Diagnostics 181
Data table 83: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 182
Data table 84: DxS Signs Cross-Licensing Agreement With Epigenomics 183
Data table 85: US Dollar to Local Currency, China, Average Actual Rate from 2002 to 2009 200

1.2 List of Charts
Chart 1: In Vitro Diagnostics, March ket Segmentation 17
Chart 2: In Vitro Diagnostics, China, Overall Sales (USD Million), from 2002 to 2016 18
Chart 3: In Vitro Diagnostics March ket, China, Sales Mix (USD Million), 2009 20
Chart 4: In Vitro Diagnostics March ket, China, Segment Contribution (%), 2009 21
Chart 5: In Vitro Diagnostics, China, Cross-Category Analysis, from 2002 to 2016 22
Chart 6: In Vitro Diagnostics, China, Overall Sales (USD Million), Historical data, from 2002 to 2009 23
Chart 7: In Vitro Diagnostics, China, Overall Sales (USD Million), Forecasted data, from 2009 to 2016 25
Chart 8: In Vitro Diagnostics, China, Market Shares (%), 2009 27
Chart 9: Clinical Chemistry, March ket Segmentation 28
Chart 10: Clinical Chemistry March ket, China, Sales Mix (USD Million), 2009 29
Chart 11: Clinical Chemistry March ket, China, Segment Contribution (%), 2009 30
Chart 12: Clinical Chemistry, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 31
Chart 13: Clinical Chemistry, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 33
Chart 14: Clinical Chemisty Analyzers, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 35
Chart 15: Clinical Chemisty Analyzers, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 37
Chart 16: Urine Analysis, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 39
Chart 17: Urine Analysis, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 41
Chart 18: Clinical Chemistry, China, Market Shares (%), 2009 44
Chart 19: Genetic Testing, March ket Segmentation 46
Chart 20: Genetic Testing March ket, China, Sales Mix (USD Million), 2009 47
Chart 21: Genetic Testing March ket, China, Segment Contribution (%), 2009 48
Chart 22: Genetic Testing, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 49
Chart 23: Genetic Testing, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 51
Chart 24: Genetic Testing, China, Market Shares (%), 2009 54
Chart 25: Haematology, March ket Segmentation 55
Chart 26: Haematology March ket, China, Sales Mix (USD Million), 2009 56
Chart 27: Haematology March ket, China, Segment Contribution (%), 2009 57
Chart 28: Haematology, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 58
Chart 29: Haematology, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 60
Chart 30: Haematology Reagents, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 62
Chart 31: Haematology Reagents, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 64
Chart 32: Immunohaematology, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 66
Chart 33: Immunohaematology, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 68
Chart 34: Haemostasis, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 70
Chart 35: Haemostasis, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 72
Chart 36: Haematology Rapid Tests, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 74
Chart 37: Haematology Rapid Tests, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 76
Chart 38: Haematology Cell Counters, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 78
Chart 39: Haematology Cell Counters, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 80
Chart 40: Haematology, China, Market Shares (%), 2009 83
Chart 41: Histology And Cytology, March ket Segmentation 85
Chart 42: Histology And Cytology March ket, China, Sales Mix (USD Million), 2009 86
Chart 43: Histology And Cytology March ket, China, Segment Contribution (%), 2009 87
Chart 44: Histology And Cytology, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 88
Chart 45: Histology And Cytology, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 90
Chart 46: Histology, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 92
Chart 47: Histology, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 94
Chart 48: Histology And Cytology, China, Market Shares (%), 2009 97
Chart 49: Immuno Chemistry, March ket Segmentation 98
Chart 50: Immuno Chemistry March ket, China, Sales Mix (USD Million), 2009 99
Chart 51: Immuno Chemistry March ket, China, Segment Contribution (%), 2009 100
Chart 52: Immuno Chemistry, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 101
Chart 53: Immuno Chemistry, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 103
Chart 54: Disease Specific Immunochemistry, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 105
Chart 55: Disease Specific Immunochemistry, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 107
Chart 56: Drug Related Testing, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 109
Chart 57: Drug Related Testing, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 110
Chart 58: Endocrinology Tests, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 112
Chart 59: Endocrinology Tests, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 114
Chart 60: Immunochemistry Analyzers, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 116
Chart 61: Immunochemistry Analyzers, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 118
Chart 62: Immuno Chemistry, China, Market Shares (%), 2009 121
Chart 63: Infectious Immunology, March ket Segmentation 123
Chart 64: Infectious Immunology March ket, China, Sales Mix (USD Million), 2009 124
Chart 65: Infectious Immunology March ket, China, Segment Contribution (%), 2009 125
Chart 66: Infectious Immunology, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 126
Chart 67: Infectious Immunology, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 128
Chart 68: Infectious Immunology, China, Market Shares (%), 2009 131
Chart 69: Microbiology Culture, March ket Segmentation 133
Chart 70: Microbiology Culture March ket, China, Sales Mix (USD Million), 2009 134
Chart 71: Microbiology Culture March ket, China, Segment Contribution (%), 2009 135
Chart 72: Microbiology Culture, China, Sales (USD Million) by Sector, Historical data, from 2002 to 2009 136
Chart 73: Microbiology Culture, China, Sales (USD Million) by Sector, Forecasted data, from 2009 to 2016 138
Chart 74: Microbiology Analyzers, China, Sales (USD Million) by Sub-Segment, Historical data, from 2002 to 2009 140
Chart 75: Microbiology Analyzers, China, Sales (USD Million) by Sub-Segment, Forecasted data, from 2009 to 2016 142
Chart 76: Microbiology Culture, China, Market Shares (%), 2009 144
Chart 77: F. Hoffmann-La Roche Ltd., Market Shares (%),China In Vitro Diagnostics March ket, 2009 145
Chart 78: Siemens Healthcare, Market Shares (%),China In Vitro Diagnostics March ket, 2009 146
Chart 79: Abbott Laboratories, Market Shares (%),China In Vitro Diagnostics March ket, 2009 147
Chart 80: Beckman Coulter, Inc., Market Shares (%),China In Vitro Diagnostics March ket, 2009 148
Chart 81: Sysmex Corporation, Market Shares (%),China In Vitro Diagnostics March ket, 2009 149
Chart 82: Mindray Medical International Limited, Market Shares (%),China In Vitro Diagnostics March ket, 2009 150
Chart 83: GlobalData Methodology 197

Companies mentionedF. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott LaboratoriesCompany Overview
Beckman Coulter, Inc.
Sysmex Corporation
Mindray Medical International Limited
OLYMPUS CORPORATION
Inverness Medical Innovations, Inc.
Becton, Dickinson and Firms
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Hologic, Inc.
Ventana Medical Systems, Inc.
Ortho-Clinical Diagnostics Inc.
DiaSorin S.p.A
Qiagen N.V.
Gen-Probe Incorporated
Phadia AB
Chengdu Perlong Medical Equipment Co., Ltd.
Shanghai Kehua Bio-engineering Co., Ltd.
China Medical Technologies, Inc.
Shanghai Genomics, Inc.
Beijing Chemclin Biotech Co., Ltd.
Beijing Pason Pharmaceuticals Inc.
Jingmei Biotech Co.,Ltd.
Beijing Bio-Ekon Biotechnology Co., Ltd.
China Sky One Medical, Inc.
Beijing Sekisui Trank Medical Technology Co., Ltd.
Shanghai Xunda Medical Instrument Co.,Ltd
Shanghai Fosun Medical Technology Development Co., Ltd.
Sichuan Nigale Biomedical Inc.
URIT Medical Electronic Group Co., Ltd
Rayto Life and Analytical Sciences Co., Ltd.
Bioson Corporation
Da An Gene Co., Ltd.
Shenzhen PG Biotech Co., Ltd.
Harbin First Bio-Engineering Co., Ltd
Beijing Shining Sun Technology Co., Ltd.
InTec Products, Inc
Zhongshan Bio-Tech Co., Ltd
Beijing BGI-GBI Biotech Co.,Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.,
GUANG ZHOU BGH BIOCHEMICAL CO.,LTD

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.